Julian A. Kim, MD
Professor, Surgical Oncologyjulian.kim@UHhospitals.org 216.844.8247 (o) 216.844.2888 (f)
The overall goal of Dr. Kim's research effort is to develop immune-based therapies for patients with cancer. He currently holds an Investigational New Drug application with the USFDA and is principal investigator on a Phase I clinical trial of T cell adoptive immunotherapy in patients with advanced melanoma. He has published over 150 manuscripts, book chapters and abstracts, has two US patents and has been funded by the American Cancer Society, Susan Komen Foundation and NIH.